2026.03.22 (일)

  • 흐림동두천 2.7℃
  • 흐림강릉 10.4℃
  • 흐림서울 5.5℃
  • 흐림대전 4.3℃
  • 흐림대구 6.6℃
  • 흐림울산 6.7℃
  • 흐림광주 6.0℃
  • 흐림부산 10.7℃
  • 흐림고창 1.6℃
  • 구름많음제주 8.8℃
  • 흐림강화 2.9℃
  • 흐림보은 1.1℃
  • 흐림금산 1.4℃
  • 흐림강진군 3.5℃
  • 흐림경주시 4.0℃
  • 흐림거제 6.9℃
기상청 제공

경제

Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index

[By NBC-1TV H. J Yook]Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index ® (Nasdaq:^NBI), effective prior to the market open on Monday, May 20.

The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities classified according to the Industry Classification Benchmark (ICB) as either Biotechnology or Pharmaceuticals. These companies must meet eligibility criteria that include a minimum market capitalization of $200 million and minimum average daily trading volume of 100,000 shares, amongst other requirements. The Index Securities are evaluated semi-annually in May and November and serve as the basis for the iShares NASDAQ Biotechnology Index Fund (Amex:IBB). For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit www.nasdaq.com.



배너

관련기사


배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너